Due to its agonist effects on alpha-2-adrenergic receptors (α<sub>2</sub>AR), it is speculated that it may have applications in the pharmacotherapy of metabolic syndrome, particularly hypertension. The gene discussed is AR; the disease is hypertensive disorder.